This was observed in a model of carcinogen and hormone-induced breast cancer, which demonstrated that RANKL inhibition with RANK-Fc significantly delayed mammary tumour formation in transgenic mice and almost completely blocked tumour formation in wild-type mice (133). Here, TNFRSF11A is linked to neoplasm.